ArticleEmerging infectious diseases2021
Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 2020
Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design.International journal of epidemiology · 2022Pooled it
- Difference in excess mortality during the COVID-19 pandemic depending on marital status in Japan.PloS one · 2026Article
- Incidence and Influencing Factors of Avoidable Mortality in Korea From 2013-2022: Analysis of Cause-of-death Statistics.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Article
- Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors.Scientific reports · 2024Article
- Time-dependent risk of COVID-19 death with overwhelmed health-care capacity in Japan, 2020-2022.BMC infectious diseases · 2022Article
- Estimating the infection burden of COVID-19 in Malaysia.PLoS neglected tropical diseases · 2022Article
- An ensemble learning strategy for panel time series forecasting of excess mortality during the COVID-19 pandemic.Applied soft computing · 2022Article
- Excess deaths from non-COVID-19-related causes in Japan and 47 prefectures from January 2020 through May 2021 by place of death.SSM - population health · 2022Article
- Exploratory analysis of the suitability of data from the civil registration system for estimating excess mortality due to COVID-19 in Faridabad district of India.The Indian journal of medical research · 2022Article
- Changes in Health Care Access during the COVID-19 Pandemic: Estimates of National Japanese Data, June 2020-October 2021.International journal of environmental research and public health · 2022Article
- Impact of the COVID-19 pandemic on changes in temperature-sensitive cardiovascular and respiratory disease mortality in Japan.PloS one · 2022Article
- The relay for human longevity: country-specific contributions to the increase of the best-practice life expectancy.Quality & quantity · 2022Article
- Geographically weighted generalized Farrington algorithm for rapid outbreak detection over short data accumulation periods.Statistics in medicine · 2021Article
- Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.Epidemiology and infection · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To provide insight into the mortality burden of coronavirus disease (COVID-19) in Japan, we estimated the excess all-cause deaths for each week during the pandemic, January-May 2020, by prefecture and age group. We applied quasi-Poisson regression models to vital statistics data. Excess deaths were expressed as the range of differences between the observed and expected number of all-cause deaths and the 95% upper bound of the 1-sided prediction interval. A total of 208-4,322 all-cause excess deaths at the national level indicated a 0.03%-0.72% excess in the observed number of deaths. Prefecture and age structure consistency between the reported COVID-19 deaths and our estimates was weak, suggesting the need to use cause-specific analyses to distinguish between direct and indirect consequences of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.